• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外构建非实体瘤模型:组织工程能走多远?

In Vitro Modeling of Non-Solid Tumors: How Far Can Tissue Engineering Go?

机构信息

Center for Biomaterials and Tissue Engineering (CBIT), Universitat Politècnica de València, 46022 Valencia, Spain.

Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 46022 Valencia, Spain.

出版信息

Int J Mol Sci. 2020 Aug 11;21(16):5747. doi: 10.3390/ijms21165747.

DOI:10.3390/ijms21165747
PMID:32796596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7460836/
Abstract

In hematological malignancies, leukemias or myelomas, malignant cells present bone marrow (BM) homing, in which the niche contributes to tumor development and drug resistance. BM architecture, cellular and molecular composition and interactions define differential microenvironments that govern cell fate under physiological and pathological conditions and serve as a reference for the native biological landscape to be replicated in engineered platforms attempting to reproduce blood cancer behavior. This review summarizes the different models used to efficiently reproduce certain aspects of BM in vitro; however, they still lack the complexity of this tissue, which is relevant for fundamental aspects such as drug resistance development in multiple myeloma. Extracellular matrix composition, material topography, vascularization, cellular composition or stemness vs. differentiation balance are discussed as variables that could be rationally defined in tissue engineering approaches for achieving more relevant in vitro models. Fully humanized platforms closely resembling natural interactions still remain challenging and the question of to what extent accurate tissue complexity reproduction is essential to reliably predict drug responses is controversial. However, the contributions of these approaches to the fundamental knowledge of non-solid tumor biology, its regulation by niches, and the advance of personalized medicine are unquestionable.

摘要

在血液系统恶性肿瘤(如白血病或骨髓瘤)中,恶性细胞具有骨髓归巢的特性,骨髓龛在肿瘤的发生和耐药中起着重要作用。骨髓的结构、细胞和分子组成以及相互作用决定了不同的微环境,这些微环境在生理和病理条件下控制着细胞的命运,并为试图复制血液癌症行为的工程化平台提供了参考,以重现其固有生物学特征。本综述总结了用于在体外有效再现骨髓某些方面的不同模型;然而,它们仍然缺乏该组织的复杂性,这对于诸如多发性骨髓瘤中耐药性发展等基本方面非常重要。细胞外基质组成、材料拓扑结构、血管化、细胞组成或干性与分化平衡等变量可在组织工程方法中进行合理定义,以实现更相关的体外模型。完全人源化的平台与天然相互作用非常相似,但仍具有挑战性,关于在多大程度上准确复制组织复杂性对于可靠预测药物反应至关重要的问题存在争议。然而,这些方法对非实体瘤生物学的基础认识、龛在其调控中的作用以及个性化医疗的发展都具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/6f50484e21a5/ijms-21-05747-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/480b33b02c3b/ijms-21-05747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/4a693d6600c6/ijms-21-05747-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/1971dce2e01f/ijms-21-05747-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/f31a02a16e19/ijms-21-05747-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/6f50484e21a5/ijms-21-05747-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/480b33b02c3b/ijms-21-05747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/4a693d6600c6/ijms-21-05747-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/1971dce2e01f/ijms-21-05747-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/f31a02a16e19/ijms-21-05747-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a28/7460836/6f50484e21a5/ijms-21-05747-g005.jpg

相似文献

1
In Vitro Modeling of Non-Solid Tumors: How Far Can Tissue Engineering Go?体外构建非实体瘤模型:组织工程能走多远?
Int J Mol Sci. 2020 Aug 11;21(16):5747. doi: 10.3390/ijms21165747.
2
Development of a 3D bone marrow adipose tissue model.开发 3D 骨髓脂肪组织模型。
Bone. 2019 Jan;118:77-88. doi: 10.1016/j.bone.2018.01.023. Epub 2018 Jan 31.
3
3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.3D组织工程化骨髓作为研究多发性骨髓瘤病理生理学和耐药性的新型模型。
Biomaterials. 2015 Dec;73:70-84. doi: 10.1016/j.biomaterials.2015.09.017. Epub 2015 Sep 12.
4
Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4.CYP3A4 介导的骨髓龛对转移性实体瘤的化学保护作用。
Cancer. 2023 Jun 1;129(11):1744-1751. doi: 10.1002/cncr.34704. Epub 2023 Feb 25.
5
Tissue engineered models of healthy and malignant human bone marrow.健康和恶性人类骨髓的组织工程模型。
Adv Drug Deliv Rev. 2019 Feb 1;140:78-92. doi: 10.1016/j.addr.2019.04.003. Epub 2019 Apr 17.
6
Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro.体外捕获生物和生物物理肿瘤微环境的工程策略。
Adv Drug Deliv Rev. 2021 Sep;176:113852. doi: 10.1016/j.addr.2021.113852. Epub 2021 Jun 28.
7
Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches.在工程化和完全人源化的 3D 龛中培养患者来源的恶性造血干细胞。
Proc Natl Acad Sci U S A. 2021 Oct 5;118(40). doi: 10.1073/pnas.2114227118.
8
Breast cancer models: Engineering the tumor microenvironment.乳腺癌模型:工程化肿瘤微环境。
Acta Biomater. 2020 Apr 1;106:1-21. doi: 10.1016/j.actbio.2020.02.006. Epub 2020 Feb 9.
9
Bioengineering the human bone marrow microenvironment in liquefied compartments: A promising approach for the recapitulation of osteovascular niches.在液化隔室中生物工程化人类骨髓微环境:一种重现骨血管龛的有前途的方法。
Acta Biomater. 2022 Sep 1;149:167-178. doi: 10.1016/j.actbio.2022.07.001. Epub 2022 Jul 8.
10
Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application.用于癌症生物学和精准医学的3D生物打印进展:从基质设计到应用
Adv Healthc Mater. 2022 Dec;11(24):e2200690. doi: 10.1002/adhm.202200690. Epub 2022 Aug 15.

引用本文的文献

1
Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro.动态刺激促进体外三维人淋巴微环境模型的功能性组织样结构形成。
Cell Rep Methods. 2025 Jul 21;5(7):101105. doi: 10.1016/j.crmeth.2025.101105. Epub 2025 Jul 11.
2
In Vitro 3D Models of Haematological Malignancies: Current Trends and the Road Ahead?血液系统恶性肿瘤的体外3D模型:当前趋势与未来之路?
Cells. 2025 Jan 2;14(1):38. doi: 10.3390/cells14010038.
3
Emerging Strategies in 3D Culture Models for Hematological Cancers.

本文引用的文献

1
"Direct to Drug" screening as a precision medicine tool in multiple myeloma.“直接药物”筛选作为多发性骨髓瘤精准医学的工具。
Blood Cancer J. 2020 May 11;10(5):54. doi: 10.1038/s41408-020-0320-7.
2
Vascularized cardiac tissue construction with orientation by layer-by-layer method and 3D printer.通过层层法和 3D 打印机构建具有定向的血管化心脏组织。
Sci Rep. 2020 Mar 26;10(1):5484. doi: 10.1038/s41598-020-59371-y.
3
Organotypic cancer tissue models for drug screening: 3D constructs, bioprinting and microfluidic chips.用于药物筛选的癌组织器官型模型:3D 构建体、生物打印和微流控芯片。
血液系统恶性肿瘤三维培养模型的新兴策略
Hemasphere. 2023 Jul 27;7(8):e932. doi: 10.1097/HS9.0000000000000932. eCollection 2023 Aug.
4
Provision and delivery of survivorship care for adult patients with haematological malignancies: A scoping review protocol.血液恶性肿瘤成年患者生存护理的提供和实施:范围综述研究方案。
PLoS One. 2023 Mar 2;18(3):e0282458. doi: 10.1371/journal.pone.0282458. eCollection 2023.
5
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML.基于水凝胶的再利用 FDA 批准药物的 AML 临床前评估。
Int J Mol Sci. 2023 Feb 20;24(4):4235. doi: 10.3390/ijms24044235.
6
Tumor-on-a-chip: Perfusable vascular incorporation brings new approach to tumor metastasis research and drug development.芯片上的肿瘤:可灌注血管整合为肿瘤转移研究和药物开发带来新方法。
Front Bioeng Biotechnol. 2022 Nov 22;10:1057913. doi: 10.3389/fbioe.2022.1057913. eCollection 2022.
7
Stability of Biomimetically Functionalised Alginate Microspheres as 3D Support in Cell Cultures.作为细胞培养中三维支架的仿生功能化藻酸盐微球的稳定性
Polymers (Basel). 2022 Oct 12;14(20):4282. doi: 10.3390/polym14204282.
8
Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion.3D生物打印在肿瘤免疫逃逸建模中的应用前景
Cancers (Basel). 2022 Jun 26;14(13):3126. doi: 10.3390/cancers14133126.
9
Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review).癌症治疗中免疫疗法的制备与应用的回顾性分析(综述)。
Int J Oncol. 2022 Feb;60(2). doi: 10.3892/ijo.2022.5302. Epub 2022 Jan 4.
10
Calcium Phosphate Coating Prepared by Microarc Oxidation Affects Expression, Molecular Presentation, and Cytokine Secretion in Tumor-Derived Jurkat T Cells.微弧氧化制备的磷酸钙涂层对肿瘤来源的Jurkat T细胞的表达、分子呈现及细胞因子分泌的影响
Materials (Basel). 2020 Sep 27;13(19):4307. doi: 10.3390/ma13194307.
Drug Discov Today. 2020 May;25(5):879-890. doi: 10.1016/j.drudis.2020.03.002. Epub 2020 Mar 9.
4
Bone marrow niches in haematological malignancies.血液恶性肿瘤中的骨髓龛。
Nat Rev Cancer. 2020 May;20(5):285-298. doi: 10.1038/s41568-020-0245-2. Epub 2020 Feb 28.
5
Could 3D models of cancer enhance drug screening?癌症的3D模型能否增强药物筛选效果?
Biomaterials. 2020 Feb;232:119744. doi: 10.1016/j.biomaterials.2019.119744. Epub 2019 Dec 26.
6
Injectable, scalable 3D tissue-engineered model of marrow hematopoiesis.可注射、可扩展的 3D 组织工程骨髓造血模型。
Biomaterials. 2020 Feb;232:119665. doi: 10.1016/j.biomaterials.2019.119665. Epub 2019 Dec 11.
7
Stem-Like Cancer Cells in a Dynamic 3D Culture System: A Model to Study Metastatic Cell Adhesion and Anti-Cancer Drugs.动态 3D 培养系统中的类干细胞:研究转移细胞黏附和抗癌药物的模型。
Cells. 2019 Nov 13;8(11):1434. doi: 10.3390/cells8111434.
8
Structure establishment of three-dimensional (3D) cell culture printing model for bladder cancer.建立膀胱癌三维(3D)细胞培养打印模型。
PLoS One. 2019 Oct 22;14(10):e0223689. doi: 10.1371/journal.pone.0223689. eCollection 2019.
9
Fate Distribution and Regulatory Role of Human Mesenchymal Stromal Cells in Engineered Hematopoietic Bone Organs.人间充质基质细胞在工程化造血骨器官中的命运分布及调控作用
iScience. 2019 Sep 27;19:504-513. doi: 10.1016/j.isci.2019.08.006. Epub 2019 Aug 7.
10
Metabolic Plasticity of Acute Myeloid Leukemia.急性髓系白血病的代谢可塑性
Cells. 2019 Jul 31;8(8):805. doi: 10.3390/cells8080805.